Pfizer’s 2024 earnings analysis highlights strong revenue guidance, strategic growth initiatives, and advancements in R&D, positioning the company for sustainable performance amid market challenges.
General Mills’ Q2 2025 earnings show resilience with a 2% revenue increase to $5.2 billion. Key growth in pet segment and strategic initiatives highlight their market competitiveness.
